4.8 Article

Synthesis and in vitro evaluation of a novel thiolated chitosan

Journal

BIOMATERIALS
Volume 26, Issue 7, Pages 819-826

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.biomaterials.2004.03.011

Keywords

thiolated chitosan; chitosan-thioethylamidine conjugates; isopropyl-S-acetylthioacetimidate.HC1; mucoadhesion

Ask authors/readers for more resources

In order to achieve the same properties as chitosan-4-thio-butyl-amidine and to overcome at the same time its insufficient stability, the ann of this study was to evaluate the imidoester reaction of isopropyl-S-acetylthioacetimidate for the chemical modification of chitosan and to study the properties of the resulting chitosan-thioethylamidine (TEA) derivative. The thioalkylamidine Substitute was introduced without the formation of N-substituted non-thiol products. The resulting conjugates exhibited 1.05 +/- 0.17% or 139.68 +/- 17.13 mumol immobilized free thiol groups per grain polymer and a total amount of reduced and oxidized thiol groups of 1.81 +/- 0.65% or 179.46 +/- 67.95 mumol/g polymer. By the immobilization of thiol groups mucoadhesion was strongly improved due to the formation of disulfide bonds with mucus glycoproteins. Chitosan-TEA was investigated regarding to its mucoadhesive properties via tensile studies and the rotating cylinder method. In tensile studies the total work of adhesion of chitosan-TEA was increased 3.3-fold in comparison to unmodified chitosan. Results from the rotating cylinder method showed an improvement ratio of 8.9 for chitosan-TEA compared with unmodified chitosan. In spite of the immobilization of thiol groups onto chitosan its swelling, behavior in aqueous solutions was not significantly altered. Cumulative release studies out of matrix tablets comprising the chitosan-TEA and the model compound fluorescence labeled dextrane (FD4) demonstrated a controlled release over 3 h with a trend toward a pseudo-zero-order kinetic. Because of these features the new chitosan thioamidine conjugate might represent a promising new polymeric excipient for various drug delivery systems. (C) 2004 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available